Variable Expression of Lung Disease Due to a Novel Homozygous ABCA3 Variant

Pediatr Allergy Immunol Pulmonol. 2022 Sep;35(3):124-128. doi: 10.1089/ped.2022.0023.

Abstract

Background: Mutations in the ATP-binding cassette transporter A3 (ABCA3) gene are one of the most common surfactant disorders leading to interstitial lung diseases (ILD). The clinical spectrum and severity of lung disease caused by ABCA3 deficiency due to missense variants is variable. Case Presentations: A novel ABCA3 c.3135G>C (p.Gln1045His) mutation was identified at the homozygous state in 3 subjects from 2 unrelated families: one 19-month-old boy with severe ILD and his homozygous pauci-symptomatic mother, and one 10-year-old girl with moderate late-onset ILD. Corticosteroid pulses associated with hydroxychloroquine were beneficial for both children. Conclusion: We illustrate here the huge intra- and interfamilial phenotypic variability associated with the same homozygous missense ABCA3 mutation, and the benefit of identifying the disease for treatment, follow-up, and appropriate genetic counseling.

Keywords: ABCA3 mutation; interstitial lung disease; surfactant protein deficiency.

Publication types

  • Case Reports

MeSH terms

  • ATP-Binding Cassette Transporters / genetics
  • Adrenal Cortex Hormones
  • Child
  • Female
  • Humans
  • Hydroxychloroquine* / therapeutic use
  • Lung Diseases, Interstitial* / diagnosis
  • Lung Diseases, Interstitial* / drug therapy
  • Lung Diseases, Interstitial* / genetics
  • Male
  • Surface-Active Agents

Substances

  • ABCA3 protein, human
  • ATP-Binding Cassette Transporters
  • Adrenal Cortex Hormones
  • Surface-Active Agents
  • Hydroxychloroquine